Evidence map›Paper›PMID 32176614›Full record

ArticleHealthcare policy = Politiques de sante2020

First Ready, First to Go: Ethical Priority-Setting of Allogeneic Stem Cell Transplant at a Major Cancer Centre.

Jennifer A H Bell, Zoe Schmilovich, Daniel Z Buchman, Marnie Escaf, Judy Costello, Hans A Messner

Abstract read
In one paragraph

Article in Healthcare policy = Politiques de sante, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Kicking Off the 2020s with Healthcare Policy.Healthcare policy = Politiques de sante · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennifer A H BellBioethicist and Research Scientist, Princess Margaret Cancer Centre, University Health Network, Toronto, ON.
Zoe SchmilovichDepartment of Human Genetics, McGill University, Montreal, QC.
Daniel Z BuchmanToronto Western Hospital, University Health Network, Toronto, ON.
Marnie EscafSenior Vice President, Princess Margaret Cancer Centre, University Health Network, Toronto, ON.
Judy CostelloSenior Clinical Director, Princess Margaret Cancer Centre, University Health Network, Toronto, ON.
Hans A MessnerFormer Director of the Allogeneic Stem Cell Transplantation Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medical advancements have now made it possible to provide allogeneic stem cell transplantation (allo-SCTs) to older patients and use stem cells from less well-matched donors. This has resulted in access to a life-saving modality for a greater number of patients with imminent life-threatening illnesses. However, resources have not always kept pace with innovation and expanded volumes. During the summer of 2015 in the province of Ontario, Canada, inadequate resources contributed to a capacity crisis, resulting in extended wait-lists for allo-SCT across the province. This situation presented unique ethical challenges, including the need for ongoing negotiations with health system partners and nimble process management to ensure timely delivery of care. This article reports on the process one organization used to determine how to equitably allocate scarce allo-SCT resources. With the ever-expanding landscape of new and emerging medical technologies, our experience has implications for the ethics of translating other increasingly expensive health technologies to clinical care.

Indexed as

Hematopoietic Stem Cell TransplantationCancer Care FacilitiesClinical Decision-MakingHumansNeoplasmsOntarioResource Allocation

Identifiers

PMID32176614
PMCPMC7075446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.